Genmab A/S (GNMSF)
OTCMKTS
· Delayed Price · Currency is USD
224.30
+6.17 (2.83%)
Jun 11, 2025, 12:39 PM EDT
Genmab Employees
Genmab had 2,682 employees as of December 31, 2024. The number of employees increased by 478 or 21.69% compared to the previous year.
Employees
2,682
Change (1Y)
478
Growth (1Y)
21.69%
Revenue / Employee
$1,224,754
Profits / Employee
$431,963
Market Cap
14.18B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 3,116 |
Elite Pharmaceuticals | 64 |
Tian'an Technology Group | 8 |
CytoDyn | 9 |
Glass House Brands | 374 |
Northwest Biotherapeutics | 25 |
American Oncology Network | 1,914 |
Silence Therapeutics | 116 |
Genmab News
- 10 days ago - Why Genmab Stock Smashed It on Monday - The Motley Fool
- 10 days ago - Genmab Announces Investigational Rinatabart Sesutecan (Rina-S®) Demonstrates Encouraging Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer in Phase 1/2 RAINFOL™-01 Trial - Business Wire
- 11 days ago - Transactions in Connection with Share Buy-back Program - GlobeNewsWire
- 16 days ago - Genmab to Participate in a Fireside Chat at the 46th Goldman Sachs Annual Global Healthcare Conference - GlobeNewsWire
- 18 days ago - Transactions in Connection with Share Buy-back Program - GlobeNewsWire
- 21 days ago - Genmab to Highlight New Data Evaluating Late-Stage Oncology Portfolio at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting - Business Wire
- 22 days ago - Genmab to Participate in a Fireside Chat at the 2025 Jefferies Global Health Care Conference - GlobeNewsWire
- 23 days ago - J&J, Genmab win FDA AdCom backing for multiple myeloma therapy - Seeking Alpha